GEN Exclusives

More »

GEN News Highlights

More »
Jun 16, 2011

Sanofi and Audion Ink Hearing Loss Research Deal

  • Sanofi entered into a two-year research collaboration with Audion Therapeutics to develop treatments for hearing loss. The companies say that they will optimize small molecules by using a regenerative medicine approach.

    The work will utilize technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory by investigator and Audion co-founder Albert Edge, Ph.D. Under terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

    Audion says it has gathered detailed knowledge of inner ear molecular biology to enable the development of drugs that can regenerate the lost hair cells and potentially restore a level of hearing. The firm is developing an IP portfolio that encompasses new molecules, delivery systems, and drug discovery tools for hearing and hearing loss research.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »